Three-dimensional mRNA measurements reveal minimal regional heterogeneity in esophageal squamous cell carcinoma
- PMID: 23219752
- PMCID: PMC3562732
- DOI: 10.1016/j.ajpath.2012.10.028
Three-dimensional mRNA measurements reveal minimal regional heterogeneity in esophageal squamous cell carcinoma
Abstract
The classic tumor clonal evolution theory postulates that cancers change over time to produce unique molecular subclones within a parent neoplasm, presumably including regional differences in gene expression. More recently, however, this notion has been challenged by studies showing that tumors maintain a relatively stable transcript profile. To examine these competing hypotheses, we microdissected discrete subregions containing approximately 3000 to 8000 cells (500 to 1500 μm in diameter) from ex vivo esophageal squamous cell carcinoma (ESCC) specimens and analyzed transcriptomes throughout three-dimensional tumor space. Overall mRNA profiles were highly similar in all 59 intratumor comparisons, in distinct contrast to the markedly different global expression patterns observed in other dissected cell populations. For example, normal esophageal basal cells contained 1918 and 624 differentially expressed genes at a greater than twofold level (95% confidence level of <5% false positives), compared with normal differentiated esophageal cells and ESCC, respectively. In contrast, intratumor regions had only zero to four gene changes at a greater than twofold level, with most tumor comparisons showing none. The present data indicate that, when analyzed using a standard array-based method at this level of histological resolution, ESCC contains little regional mRNA heterogeneity.
Copyright © 2013 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.
Figures



Similar articles
-
Identification of differentially expressed genes in esophageal squamous cell carcinoma (ESCC) by cDNA expression array: overexpression of Fra-1, Neogenin, Id-1, and CDC25B genes in ESCC.Clin Cancer Res. 2001 Aug;7(8):2213-21. Clin Cancer Res. 2001. PMID: 11489794
-
Profiling of differentially expressed cancer-related genes in esophageal squamous cell carcinoma (ESCC) using human cancer cDNA arrays: overexpression of oncogene MET correlates with tumor differentiation in ESCC.Clin Cancer Res. 2001 Nov;7(11):3519-25. Clin Cancer Res. 2001. PMID: 11705871
-
Protein and gene expression characteristics of heterogeneous nuclear ribonucleoprotein H1 in esophageal squamous cell carcinoma.World J Gastroenterol. 2016 Aug 28;22(32):7322-31. doi: 10.3748/wjg.v22.i32.7322. World J Gastroenterol. 2016. PMID: 27621578 Free PMC article.
-
BRCA1-Associated Protein Increases Invasiveness of Esophageal Squamous Cell Carcinoma.Gastroenterology. 2017 Nov;153(5):1304-1319.e5. doi: 10.1053/j.gastro.2017.07.042. Epub 2017 Aug 2. Gastroenterology. 2017. PMID: 28780075
-
Transcriptome profiling of lncRNA and co-expression networks in esophageal squamous cell carcinoma by RNA sequencing.Tumour Biol. 2016 Oct;37(10):13091-13100. doi: 10.1007/s13277-016-5227-3. Epub 2016 Jul 23. Tumour Biol. 2016. PMID: 27449043
Cited by
-
Global comparative transcriptomes uncover novel and population-specific gene expression in esophageal squamous cell carcinoma.Infect Agent Cancer. 2023 Aug 28;18(1):47. doi: 10.1186/s13027-023-00525-8. Infect Agent Cancer. 2023. PMID: 37641095 Free PMC article.
-
Genomic Characterization and Comparison of Multi-Regional and Pooled Tumor Biopsy Specimens.PLoS One. 2016 Mar 24;11(3):e0152574. doi: 10.1371/journal.pone.0152574. eCollection 2016. PLoS One. 2016. PMID: 27010638 Free PMC article.
-
CD39-Expressing CD8+ T Cells as a New Molecular Marker for Diagnosis and Prognosis of Esophageal Squamous Cell Carcinoma.Cancers (Basel). 2023 Feb 13;15(4):1184. doi: 10.3390/cancers15041184. Cancers (Basel). 2023. PMID: 36831526 Free PMC article.
-
Deciphering intratumor heterogeneity using cancer genome analysis.Hum Genet. 2016 Jun;135(6):635-42. doi: 10.1007/s00439-016-1670-x. Epub 2016 Apr 28. Hum Genet. 2016. PMID: 27126234 Review.
-
Multi-region sequencing with spatial information enables accurate heterogeneity estimation and risk stratification in liver cancer.Genome Med. 2022 Dec 16;14(1):142. doi: 10.1186/s13073-022-01143-6. Genome Med. 2022. PMID: 36527145 Free PMC article.
References
-
- Kamangar F., Dores G.M., Anderson W.F. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol. 2006;24:2137–2150. - PubMed
-
- Parkin D.M., Bray F., Ferlay J., Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74–108. - PubMed
-
- Jemal A., Siegel R., Xu J., Ward E. Cancer Statistics, 2010. CA Cancer J Clin. 2010;60:277–300. [Erratum appeared in CA Cancer J Clin 2011, 61:133–134] - PubMed
-
- Pisani P., Bray F., Parkin D.M. Estimates of the world-wide prevalence of cancer for 25 sites in the adult population. Int J Cancer. 2002;97:72–81. - PubMed
-
- Travis W.D. Pathology of lung cancer. Clin Chest Med. 2002;23:65–81. viii. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases